The clinical course of patients experiencing recurrence following hepatectomy for colorectal cancer metastases (CRM) is poorly defined. Previous studies associated shorter time to recurrence (TTR) in months, node‐positive primary tumor,… Click to show full abstract
The clinical course of patients experiencing recurrence following hepatectomy for colorectal cancer metastases (CRM) is poorly defined. Previous studies associated shorter time to recurrence (TTR) in months, node‐positive primary tumor, and more than one site of recurrence with worse outcomes.
               
Click one of the above tabs to view related content.